50% glycerol, 50% PBS, pH 7.4
Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4ºC.
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Human IgG1 kappa negative control , monoclonal Human IgG1 isotype control , Human IgG1 negative control , Isotype control to Human IgG1 kappa , Hum , Isotype control for Human IgG1 kappa , Human IgG1 isotype control , Negative control for Human IgG1 kappa
Inclusion of an appropriate isotype control is essential for the proper interpretation of experimental results. Because isotype control antibodies have no relevant specificity, they enable the researcher to distinguish non-specific "background" binding from antigen-specific antibody binding. Non-specific binding of primary antibodies may occur due to either binding of antibody to Fc receptors or non-specific interactions with cellular proteins, lipids, or carbohydrates. Additionally, autofluorescence or endogenous enzyme activity in target cells may give a false positive that could be misinterpreted as antibody binding. These factors vary by target cell type and the isotype of the primary antibody. Therefore, the primary antibody used should be matched to an isotype control of identical species and isotype (including both heavy and light chains).